Journal of Pharmacy Namira (JPN) is committed to meet and uphold standards of ethical behavior at all stages of the publication process.

Ethical issues that need to be adhered to before submission:

• Authorship:

Authorship should be limited to those who significantly contributed to the study. A maximum of 6 authors are allowed. Papers having more than 6 persons need to list each author role for editorial consideration.

• Originality and plagiarism:

Submissions must be completely original works. Results or information from other studies must be cited or quoted. Authors are recommended to use plagiarism software before submission.

• Disclosure on conflict of interest

Authors must disclose any conflict of interest

• Multiple, redundant or concurrent publication:

Authors must not submit multiple, redundant or concurrent publications. Salami slicing and publication in multiple languages must be avoided.

• Human and animal subjects

Human or animal ethical approval should be stated in the article and must be submitted for editorial board approval.

• Use of patient images

Ethical committee approval and informed consent proof must be submitted before the work can be considered by the journal.